Molly Dir - Aptinyx VP HR
APTXDelisted Stock | USD 0.07 0.01 16.67% |
Insider
Molly Dir is VP HR of Aptinyx
Phone | 847 871 0377 |
Web | https://www.aptinyx.com |
Aptinyx Management Efficiency
The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.Aptinyx currently holds 22.11 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Aptinyx has a current ratio of 15.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aptinyx's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
David Hanley | Nuvation Bio | 54 | |
Jason Davis | Virax Biolabs Group | 52 | |
MD DrSc | Allarity Therapeutics | 81 | |
MBA MD | Spero Therapeutics | 43 | |
Ben MD | Neurobo Pharmaceuticals | 68 | |
Dr IV | Assembly Biosciences | 52 | |
Annie Rasmussen | Allarity Therapeutics | 67 | |
Satyavrat CFA | Spero Therapeutics | 51 | |
Professor MD | Allarity Therapeutics | 67 | |
Daniel Welch | Nuvation Bio | 63 | |
Timothy Moore | Instil Bio | 63 | |
MHROD SHRMSCP | Assembly Biosciences | N/A | |
TsungShann Jiang | ABVC Biopharma | 70 | |
Rowena Albanna | Aditxt Inc | 58 | |
Claus Pedersen | Allarity Therapeutics | 52 | |
Karl MD | Achilles Therapeutics PLC | 57 | |
Ian Critchley | Spero Therapeutics | N/A | |
DPHIL DPhil | CytomX Therapeutics | 57 | |
Cameron Shaw | Virax Biolabs Group | 37 | |
W Vernon | Nuvation Bio | 65 | |
Lawrence CPA | Adial Pharmaceuticals | 68 |
Management Performance
Return On Equity | -1.38 | |||
Return On Asset | -0.51 |
Aptinyx Leadership Team
Elected by the shareholders, the Aptinyx's board of directors comprises two types of representatives: Aptinyx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptinyx. The board's role is to monitor Aptinyx's management team and ensure that shareholders' interests are well served. Aptinyx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptinyx's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathryn King, VP Operations | ||
Norbert Riedel, President CEO, Director | ||
Patrick Flavin, Sr Relations | ||
Molly Dir, VP HR | ||
Ashish Khanna, Chief Business Officer | ||
Harald MD, VP Affairs | ||
Tim Noffke, VP Staff | ||
MD BCh, Pres CEO |
Aptinyx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptinyx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.38 | |||
Return On Asset | -0.51 | |||
Current Valuation | (25.91 M) | |||
Shares Outstanding | 67.72 M | |||
Shares Owned By Insiders | 13.12 % | |||
Shares Owned By Institutions | 42.96 % | |||
Number Of Shares Shorted | 2.23 M | |||
Price To Earning | (5.61) X | |||
Price To Book | 0.33 X | |||
Price To Sales | 45.33 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Aptinyx Stock
If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |